Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Intelligent Beauty secures funding

This article was originally published in The Rose Sheet

Executive Summary

Venture capital firm Technology Crossover Ventures (TCV) has acquired a minority stake in Intelligent Beauty. Terms of the deal were not disclosed. Intelligent Beauty - which focuses on building prestige beauty brands through digital marketing and distribution channels - says it will use the capital to "scale and expand its portfolio of brands through strategic acquisitions and increased media purchasing and marketing efforts." Ian Picache of TCV will join the company's board of directors, but its current owners will retain majority ownership. "TCV has a proven track record for helping to build high-growth e-commerce companies like Intelligent Beauty. We look forward to working with TCV to capitalize on the unprecedented growth opportunities of the Internet and home shopping," Don Ressler, Intelligent Beauty co-founder and co-CEO, remarks. TCV's investment marks Intelligent Beauty's first external round of funding...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS014991

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel